abstract |
The present invention relates to novel recombinant vaccines providingnprotective immunity against tuberculosis. Further, the present inventionnrefers to novel recombinant nucleic acid molecules, vectors containing saidnnucleic acid molecules, cells transformed with said nucleic acid moleculesnand polypeptides encoded by said nucleic acid molecules. |